Introduction
Throughout the United Kingdom elixirs containing either diamorphine or morphine are used to relieve pain in advanced malignant disease. As part of a comprehensive evaluation of such preparations, it was decided to study the urinary excretion of morphine in a group of patients receiving diamorphine or morphine by mouth every 4 hours. Previous investigation of the urinary excretion of morphine in the non-addict has been limited to recovery following a single dose of injected morphine (Oettel, 1950;  Elliott, Tolbert, Adler & Anderson, 1954; Paerregaard, 1957 of urine collection was 4 weeks, ranging from less than 2 days to more than 6 months. It was greatest in the oral morphine group (7 weeks) and least in the injected diamorphine group (2 weeks).
By mouth, either diamorphine hydrochloride or morphine sulphate was given in an elixir which also contained alcohol, cocaine and either prochlorperazine or chlorpromazine. On account of its limited shelf life, elixirs containing diamorphine were discarded if not used within 2 weeks of preparation (Twycross, 1974 All the patients had been on a steady dose for at least 3 days before the urine collection, the majority for more than 2 weeks. With the exception of four men, all had a catheter in situ. Urine volume was measured and samples for the determination of morphine kept at -20°C. Subse%uently, the samples were incubated overnight at 37 C with ,B-glucuronidase to hydrolyse the conjugated morphine. The total morphine content was then assayed by gas-liquid chromatography using [14C] -morphine to correct for losses during extraction (Fry, Wills & Twycross, 1974) . The percentage of administered diamorphine hydrochloride or morphine sulphate recovered as morphine in the urine was calculated taking into account their different molecular weights. Mean 24 h urinary recovery was determined for each of the three groups. Urinary creatinine was measured by an automated method (Autoanalyser Method NI 1).
Results
The results from one patient who received diamorphine by mouth were excluded on account of an exceptionally low urine output (122 ml/24 hours). The results from the other patients are summarized in Table 1 . There is no significant difference at the 5% level between the mean 24 h creatinine excretion in the three groups, suggesting that the different percentage recoveries were not simply the result of variation in renal function.
In patients receiving diamorphine or morphine by mouth, there is a significant difference at the 5% level in the mean urinary recovery of morphine (t = 2.1, d.f. 25, 0.05 > P> 0.01). On the other hand, no significant difference exists between the mean urinary recovery of morphine in the two diamorphine receiving groups (t = 0.71, d.f. 27, P > 0.4).
The urinary morphine recovery correlated closely with the dose administered (Fig. 1) . Linear correlation coefficients for the three groups were: injected diamorphine, r = + 0.65 (P < 0.05), oral diamorphine, r = + 0.94 (P< 0.001), oral morphine, r= + 0.83 (P< 0.01) and for all the patients r = + 0.82 (P< 0.001). The mean urinary recoveries in the present study are higher than those reported after single parenteral doses of morphine (Paerregaard, 1957) or after short-term infusions of diamorphine (Elliott, Parker, Wright & Nomof, 1971) . Differences in analytical techniques might account in part for this but probably more important is the fact that all our subjects had been receiving diamorphine or morphine for some time before the urine collection. In these circumstances, diamorphine, morphine and their biotransformation products will have reached equilibrium throughout the body compartments.
In an earlier report (Fry et al., 1974) , we emphasized that there is considerable variation in the urinary excretion of morphine in individual patients from day to day, even when receiving regular steady doses of diamorphine or morphine. Mo & Way (1966) noted similar variation in diamorphine (heroin) addicts receiving repeated known quantities of diamorphine but, despite this, found that the daily group mean urinary excretion of morphine remained virtually constant over 3 days.
Assuming that diamorphine by injection is completely absorbed from the injection site, we postulate that, with our method, a urinary recovery of some 70% represents 00% absorption. This postulate is supported by Mo & Way (1966) of equivalence to who reported a similar recovery (68%) following repeated intravenous administration.
There was no statistical difference between the mean recovery of morphine in those receiving diamorphine hydrochloride by mouth and those receiving it by injection. The recovery following orally administered morphine sulphate was significantly lower. However, the doses of morphine sulphate were, on average, larger than those of diamorphine hydrochloride but there is no evidence of a definite decline in the urinary recovery at the higher dose levels. We conclude, therefore, that an orally administered solution of diamorphine hydrochloride is completely absorbed by the gastro-intestinal tract but that a solution of morphine sulphate is only some two-thirds absorbed.
Many questions remain unanswered: we know nothing, for example, of the rate of absorption of the two preparations or what proportion of the total morphine recovered was previously circulating in a pharmacologically active, nonconjugated form. A more detailed study of serum morphine levels is currently being undertaken to answer these and other questions. 
